Profil
Guy Chatelain is currently a Director at EUSA Pharma SAS, Indufina, Industrielle et Financière Holding Genève SA, Cellmark SA, Ms Medical Synergy SA, a Member of the Swiss Bar Association, Geneva Association of Business Law, and Geneva Bar Association.
He was previously the President & Managing Director at Seventure Partners SA, a Director at Orphan Synergy Europe-Pharma SA, and a Director at OSE Immunotherapeutics SA from 2012 to 2018.
He was also a Principal at Pestalozzi Lachenal Patry from 1977 to 1984 and a Partner & Attorney at Law at Mentha & Associés.
Mr. Chatelain holds an MBA from École des Hautes Études Commerciales de Paris.
Aktive Positionen von Guy Chatelain
| Unternehmen | Position | Beginn |
|---|---|---|
Geneva Bar Association | Corporate Officer/Principal | - |
Swiss Bar Association
Swiss Bar Association Swiss Bar Association is a company. 'The company is based in Bern, Switzerland. | Corporate Officer/Principal | - |
Geneva Association of Business Law | Corporate Officer/Principal | - |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Direktor/Vorstandsmitglied | - |
Ms Medical Synergy SA
Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | - |
Cellmark SA
Cellmark SA Wholesale DistributorsDistribution Services Wholesales cellulose and paper products | Direktor/Vorstandsmitglied | - |
Indufina, Industrielle et Financière Holding Genève SA | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Guy Chatelain
| Unternehmen | Position | Ende |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Direktor/Vorstandsmitglied | 03.01.2018 |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Vorstandsvorsitzender | 01.01.2013 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Guy Chatelain
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Pestalozzi Lachenal Patry
Pestalozzi Lachenal Patry Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Finance |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mentha & Associés
Mentha & Associés Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Health Technology |
Swiss Bar Association
Swiss Bar Association Swiss Bar Association is a company. 'The company is based in Bern, Switzerland. | |
Geneva Association of Business Law | |
Geneva Bar Association | |
Indufina, Industrielle et Financière Holding Genève SA | |
Cellmark SA
Cellmark SA Wholesale DistributorsDistribution Services Wholesales cellulose and paper products | Distribution Services |
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Ms Medical Synergy SA
Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
OSE Immunotherapeutics SA
OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
















